posted
these are some reasons why fonar is a good value play.
from another post
- P/E of 8 with potential to be traded at a P/E of 17. - Booked value $4 per share increasing by $2.5 per share year on year. - Cash $1.6 per share. - Equity included minority interests $45M - solvency of 60%. - Loss carry forwards of more than $140M - no income taxes the next 15 years. - A product with significant advantages to the market, because of Fonar's patents. - New market potential from FONAR UPRIGHT® Multi-Position™ MRI, scanning diseases such as multiple sclerosis etc. - Growth is expected in 2014/2015 according to managements plans to acquire additional centers in New York and Florida. - Fonar records eighteen straight quarter of positive net income and income from operations. - Fonar traded at $27.95 within the last 12 month. - My expectations: We are heading back above $28 within the next 12 month. A rise of more than 120% from todays level. Less
. .
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
Fonar Corporation engages in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, and other medical conditions and injuries. The company operates through two segments, Manufacturing and Servicing of Medical Equipment; and Management of Diagnostic Imaging Centers. It provides Upright Multi-Position MRI scanner, which allows patients to be scanned in fully weight-bearing conditions, such as standing, sitting, or bending in any position that causes adverse symptoms. Fonar Corporation markets its scanners to private diagnostic imaging centers and hospitals. The company also offers management services to diagnostic imaging facilities, which include development, administration, and leasing of office space, facilities, and medical equipment; and is involved in the provision of supplies; staffing, training, and supervision of non-medical personnel; legal services; accounting, billing, and collection; and the development and implementation of practice growth and marketing strategies. As of June 30, 2014, it managed 11 diagnostic imaging facilities located in the states of New York and Florida. Fonar Corporation was founded in 1978 and is based in Melville, New York
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
FONAR (NASDAQ: FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 FONAR recumbent-OPEN MRIs and 157 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR's stellar product is the UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and the only MRI scanner that is able to scan patients in the exact weight-loaded position that is generating their pain. It scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient's problem that other scanners cannot because they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, then they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. FONAR is headquartered on Long Island, New York.
UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Landscape™, CSP™, Dynamic™ and Spondylometry™ are trademarks of FONAR® Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
Contact:
Daniel Culver Director of Communications E-mail: Email Contact
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
MELVILLE, NY--(Marketwired - Sep 15, 2014) - Fonar Corporation (NASDAQ: FONR) •39% Increase of Fiscal 2014 Net Revenues to $68.5 million versus prior year •31% Increase of Fiscal 2014 Net Income to $13.4 million versus prior year •18% Increase of Fiscal 2014 Diluted Net Income per Common Share available to Common Shareholders to $1.58 versus prior year •63 % Increase of Fiscal 2014 Income from Operations to $12.3 million versus prior year
Fonar Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, today announced its 2014 fiscal year-end results. The Company's two industry segments are: development, manufacturing and servicing of the UPRIGHT® Multi-Position™ MRI and management of Stand-Up® MRI (UPRIGHT® MRI) centers. The FONAR UPRIGHT® Multi-Position™ MRI scanner is the world's only MRI scanner licensed under FONAR's multiple UPRIGHT® MRI patents to scan all the patient's body parts in their normal full weight-bearing UPRIGHT® position.
Financial Highlights Revenues increased 39% to $68.5 million for the fiscal year ended June 30, 2014 as compared to $49.1 million for fiscal year ended June 30, 2013.
Revenues from the management of the diagnostic imaging center segment, consisting of patient and management fee revenue, increased 65% to $56.4 million for the year ended June 30, 2014, as compared to $34.3 million over the comparable period one year earlier.
Net income increased 31% to $13.4 million for the fiscal year ended June 30, 2014 as compared to $10.3 million for the earlier corresponding fiscal year.
Income from operations increased 63% to $12.3 million for the fiscal year ended June 30, 2014 from $7.5 million for the fiscal year ended June 30, 2013.
Diluted net income available to common shares for the fiscal year ending June 30, 2014 was $1.58, which includes a partial reversal of the deferred tax valuation allowance of $2.7 million, or $0.45.
Total cash and cash equivalents increased 26% to $10.0 million at June 30, 2014, from $7.9 million at June 30, 2013.
Management Discussion Raymond V. Damadian, M.D., president and chairman of Fonar Corporation, said, "the Company has grown and prospered significantly over the past year as evidenced by our outstanding financial results. This is in spite of some cuts in MRI reimbursements brought about by the Affordable Care Act. This is in large part due to the extraordinary abilities of the FONAR UPRIGHT® Multi-Position™ MRI, as well as our fine management staff."
"A year and half have passed since the acquisition of the business of Health Diagnostics Management (HDM) and we can look back and see how advantageous acquiring these centers was," continued Dr. Damadian. "By combining the resources of our wholly owned subsidiary, Health Management Corporation of America (HMCA), and HDM, we have seen the benefits of economies of scale, shared technical and administrative expertise and capabilities, and joint marketing strategies. In the future, we expect to facilitate growth of imaging centers through acquisitions, supporting new UPRIGHT® imaging centers, and increasing scan volume at our existing locations by continuing to educate the medical community about the unique diagnostic advantages of UPRIGHT® Multi-Position™ fully weight-loaded MRI. The new HMCA has 23 FONAR weight-bearing MRI scanners and is the largest of its kind in the world."
"Our successful business model is made possible by the success of our current MRI scanner, the UPRIGHT® Multi Position™ (Stand-Up®) MRI," continued Dr. Damadian. "This scanner is extremely popular with patients who experience claustrophobia or can't lie down for long periods. The FONAR UPRIGHT® MRI provides unduplicated benefits in assessing the position dependence of patient symptoms. The UPRIGHT® MRI's ability to make MRI motion pictures (cinés) of the cerebrospinal fluid (CSF) as it flows into and out of the upright brain and spine enables visualization of obstructions of CSF flow not found in other MRIs and leading to new understandings of the genesis of diseases such as multiple sclerosis (MS).
Significant Event On July 17, 2014, the HDM scanning center in Naples, Florida, won the 'People's Choice Award' after being selected by readers of the Naples Daily News. Stand-Up MRI of SW Florida was selected for the category of 'Best Imaging Center'. Naples, Florida is among America's most affluent communities.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
I have been in and out of fonar since it was about 1.47 a share.
it is a very solid company and makes moneyI am reinvested at $10 and I am sure I will double my money over the long haul IMO only.
This not the usual pump and dump that is so prevalent on these boards. Most of fonars battles for survival have ben fought and now they can concentrate on making money.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
fonar up .09 cents out of the gate at low volume this morning. I am going away for a couple of days to relax might check in on my lap top. If not see all of you later.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
MELVILLE, NY--(Marketwired - Oct 7, 2014) - Fonar Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, today announced it has sold its UPRIGHT® Multi-Position™ MRI to a customer in Dubai, United Arab Emirates (UAE). This will be the first sale to a customer in the United Arab Emirates. The FONAR UPRIGHT® Multi-Position™ MRI (aka Stand-Up® MRI) scanner is the world's only MRI scanner licensed under FONAR's multiple UPRIGHT® MRI patents to scan all the patient's body parts in their normal multiple, fully weight-bearing UPRIGHT® positions
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
Research Team (Sep 22), The Street (Sep 18), Market Edge (Sep 23) and Jaywalk Consensus (Aug 31) all upgraded Fonar to a buy.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
First Sale to Alaska of FONAR Upright Multi-Position MRI Announced
.
Marketwired Fonar Corporation 9 hours ago
MELVILLE, NY--(Marketwired - Oct 22, 2014) - Fonar Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, today announced a sale of its UPRIGHT® Multi-Position™ MRI to a customer in Wasilla, Alaska. The customer is John McCormick, M.D., a Harvard trained radiologist who has purchased the scanner for his practice. The FONAR UPRIGHT® Multi-Position™ MRI (aka Stand-Up® MRI) scanner is the world's only MRI scanner licensed under FONAR's multiple UPRIGHT® MRI patents to scan all the patient's body parts in their normal multiple, fully weight-bearing UPRIGHT® positions. Dr. McCormick said, "I am purchasing the FONAR because of its unique ability to scan patients upright and in the weight-bearing position. We have a recumbent high-field MRI but there are too many patients who exhibit their pain and symptoms only when upright, so we aren't able to find their problem. In fact, sometimes the supine MRI gives misleading information. Scanning patients upright will have its greatest need in cervical and lumbar spine studies."
Dr. McCormick continued, "We can see how the UPRIGHT® Multi-Position™ MRI will be of great help for range-of-motion studies and the ability to scan in flexion and extension. Many of our referring physicians are podiatrists who currently use upright x-ray. So, they will soon have the ability to obtain those upright scans showing the soft tissue of the feet."
Dr. McCormick said that Alaska is a certificate of need (CON) state but if possible he would purchase a second FONAR soon. This will be the first installation of an UPRIGHT® MRI in the state of Alaska. It is the 30th state where FONAR has sold an UPRIGHT® Multi-Position MRI.
Raymond V. Damadian, M.D., president and founder of Fonar Corporation said, "We are pleased that Dr. McCormick has purchased our UPRIGHT® MRI and we are anxious to help the citizens of Alaska with this important technology. There is a pandemic in our nation of people suffering from neck pain, including 1.2 million whiplash injuries each year in the U.S. We call the condition the Cranio-Cervical Syndrome, and it concerns the vulnerability of the human neck and its impact on cerebrospinal fluid (CSF) flow throughout the brain and spine. I am pleased that many people are helped by the UPRIGHT® MRI such as Jim McMahon, the former NFL quarterback."
Newsday, the leading Long Island Newspaper, ran a story in sporting section of its Sunday edition on October 12, 2014. The story was titled 'Jim's McMiracle -- Headaches and memory loss destroyed his quality of life until two LIers came to the rescue.'
Former NFL Quarterback Jim McMahon had suffered from post-concussion dementia and was scanned on the UPRIGHT® MRI at the Company's Melville facility in November, 2012. In addition to spine and brain scans, a FONAR UPRIGHT® CSF flow (cińe) video was performed which demonstrated a significant obstruction of CSF flow and increased intracranial pressure secondary to prior football injuries to Jim's cervical spine.
Subsequently, he was treated by Dr. Scott Rosa, of the Trauma Imaging Foundation, www.traumaimagingfoundation.com . Dr. Rosa treated Jim with his patented IGAT (Image Guided Atlas Treatment) method. Jim gives much credit to Dr. Raymond Damadian, M.D., president and founder of FONAR, the FONAR UPRIGHT® Multi-Position™ MRI and Dr. Scott Rosa, for the wonderful elimination of his headache pain and memory impairments. See http://www.fonar.com/news/052114.htm.
Dr. Damadian commented, "We thank Jim McMahon for his comments but most important is pointing out that it was unrecognized problems in Jim's neck that were uncovered by FONAR's UPRIGHT® Multi-Position MRI images that made the difference. Jim's UPRIGHT® MRI images enabled Dr. Rosa to successfully treat Jim's neck and overcome his symptomology."
About FONAR FONAR (NASDAQ: FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 FONAR recumbent-OPEN MRIs and 157 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR's stellar product is the UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and the only MRI scanner that is able to scan patients in the exact weight-loaded position that is generating their pain. It scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient's problem that other scanners cannot because they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, then they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. FONAR is headquartered on Long Island, New York.
UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Landscape™, CSP™, Dynamic™ and Spondylometry™ are trademarks of FONAR® Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
Contact:
Daniel Culver Director of Communications E-mail: Email Contact www.fonar.comPosts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
I really think that fonar is on the brink of some big that we can all make a lot of money off of.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
fonar is now trading at 12.05. I am waiting for a pull back to buy more.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
looks like we are retreating today if fonar goes low enough it will be a good buying opportunity lets see where it consolidates at.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
FONAR Sells Fifth Upright Multi-Position MRI to Germany MELVILLE, NY--(Marketwired - Oct 28, 2014) - Fonar Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, today announced a sale of its UPRIGHT® MRI to a long-time FONAR customer, Medserena, of Germany. The FONAR UPRIGHT® Multi-Position™ MRI (aka Stand-Up® MRI) scanner is the world's only MRI scanner licensed under FONAR's multiple UPRIGHT® MRI patents to scan all the patient's body parts in their normal multiple, full weight-bearing UPRIGHT® positions. This will be the fifth sale of a FONAR UPRIGHT MRI in Germany.
The UPRIGHT® MRI will be placed in the city of Frankfurt. This will join the cities of Cologne, Hanover, Munich, and Hamburg that currently have the FONAR UPRIGHT® Multi-Position™ MRI. Medserena CEO Matthias Schulz has said, "A large number of requests for the FONAR UPRIGHT® Multi-Position™ MRI are coming from physicians in Germany because of the special medical need for FONAR's unique technology. This is in spite of an intensely active MRI market in Germany, where there are already many conventional lie-down MRIs installed."
Raymond V. Damadian, M.D., president and founder of Fonar Corporation, said, "I am pleased to announce this fifth sale of the UPRIGHT® Multi-Position™ MRI to our German customer. It is good to see that there is still robust interest for our scanner in the MRI marketplace."
Dr. Damadian continued, "We have now had a third press release during the month of October featuring sales of our UPRIGHT® Multi-Position™ MRI. Sales of the scanner are a good complement to our subsidiary, Health Management Corporation of America (HMCA), which manages diagnostic imaging centers which have the FONAR UPRIGHT® (Stand-Up®) MRI.
"The FONAR UPRIGHT® weight-bearing MRI technology and its critical role in optimizing outcomes from spine surgery, provides unduplicated benefits in assessing the position dependence of patient symptoms. The UPRIGHT® MRI's ability to make MRI motion pictures (cinés) of the cerebrospinal fluid (CSF) as it flows into and out of the upright brain and spine enables visualization of obstructions of CSF flow not found in other MRIs and leading to new understandings of the genesis of diseases such as multiple sclerosis (MS)," said Dr. Damadian.
"The FONAR UPRIGHT® MRI is the only scanner which can properly identify a disease we call the Cranio-Cervical Syndrome," continued Dr. Damadian. "The primary symptomology of the the Cranio-Cervical Syndrome is pressure headaches but there are many variations." For further details visit http://www.fonar.com/news/032813.htm.
"In addition," said Dr. Damadian, "the FONAR UPRIGHT® MRI is essential in understanding the impact of whiplash due to a motor vehicle accident." For a peer reviewed paper titled 'A case-control study of cerebellar tonsillar ectopia (Chiari) and head/neck trauma (whiplash)' visit: http://traumaimagingfoundation.com/research.
About FONAR FONAR (NASDAQ: FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 FONAR recumbent-OPEN MRIs and 157 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR's stellar product is the UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and the only MRI scanner that is able to scan patients in the exact weight-loaded position that is generating their pain. It scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient's problem that other scanners cannot because they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, then they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. FONAR is headquartered on Long Island, New York
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
Great news this month. Fonar sell 3rd Upright multi-position MRI within 3 weeks. Sales to United Arab Emirates, Alaska and now Gemany. What a great month! From articlses I read the sales price of an Upright multi-position MRI unit exceed $1.5M. In fiscal year 2014 product sales net was $1.9M.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
closed today up 1.12 closed at 12.75 in todays trading I might not get my buying opportunity at the price I want.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
fonar closed at 12.62 today it seems to be holding its own even on low volume
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
Next week FONR is expected to release Q1 2015 earnings report. I expect EPS of $0.35-0.40. If you compare my estimate Q1 2015 EPS to Q4 2014 EPS without the tax reversal, the Q4 2014 EPS was $0.19. Q1 2015 EPS (without tax reversal) is going to increase by 80-100% compared to Q4 2014. I expect Q1 2015 revenue of $16.8-17.0M and income from operations of $3.1 - 3.5M. Net income controlling interests of $2.3 - 2.6M. I expect gross profit in Q1 2015 of 44.0% compared to 45.1% in Q4 2014. I don't expect other expenses in Q1 2015. In Q4 2014 other expenses were $0.5M. I expect provisions for bad debts to be reduced from $1.0M in Q4 2014 to $0.2M in Q1 2015. My estimate on fiscal year 2015 is EPS (without tax reversal) of $1.55-1.65. Revenue of $72-73M a growth of 6.0-6.5% due to product sales increase of $4-6M. Income before provision for income taxes of $13.5-14.5M. Cash of $14-16M in June 2015. Less
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
Financial Highlights The Company's total revenues increased 7% to $18.0 million for the quarter ended September 30, 2014 as compared to $16.8 million during the same period a year earlier.
The acquisition of Health Diagnostics in March 2013 added 14 MRI Centers under management to the original 11 MRI centers. One year ago, the Company reported a 149% increase for this management of diagnostic imaging center segment to $14.3 million for the quarter ended September 30, 2013 as compared to $5.7 million for the quarter ended September 30, 2012. Now, one year later, revenues in this segment are approximately $14.2 million for the quarter ended September 30, 2014.
Basic net income available to common stockholders for the quarter ended September 30, 2014 increased 3% to $0.39 as compared to $0.38 during the same quarter ended one year earlier. Diluted net income available to common stockholders for the quarter ended September 30, 2014 increased 3% to $0.38 as compared to $0.37 during the same quarter ended one year earlier. Net Income for the quarter ended September 30, 2014 was $3.3 million as compared to $3.6 million for the same quarter one year earlier.
Total assets at September 30, 2014 were $78.8 million, as compared to $76.8 million at June 30, 2014. Total current assets at September 30, 2014 were $45.6 million, as compared to $42.8 million at June 30, 2014.
Total liabilities at September 30, 2014 were $30.7 million, as compared to $30.9 million at June 30, 2014. Total current liabilities at September 30, 2014 were $22.0 million, as compared to $21.2 million at June 30, 2014.
Stockholder's equity at September 30, 2014 was $48.1 million, as compared to $45.9 million at June 30, 2014.
Cash and cash equivalents increased 7% to $10.7 million at September 30, 2014, from $10.0 million at June 30, 2014.
Management Discussion Raymond V. Damadian, president and chairman of Fonar Corporation said, "Over the past year and a half we have accomplished much. We acquired a business which allowed us to roughly double our size and successfully merged the companies allowing us to share capabilities and administrative and technical expertise. This gave us a synergy of joint marketing strategies, and many other economies of scale."
"Overall," said Dr. Damadian, "we have mitigated the increased pressure due to cuts in MRI reimbursements brought about by the Affordable Care Act. This was because of the adherence to our ongoing business plan which has made the difference."
"Perhaps, we can give some credit to the uniqueness and practicality of our UPRIGHT® full weight-loaded MRI scanner, which is immensely popular with both physician and patient. As Fonar's customer, Medserena, pointed out on their purchase of their fifth scanner for Germany, 'a large number of requests for the FONAR UPRIGHT® Multi-Position™ MRI are coming from physicians in Germany because of the special medical need for FONAR's unique technology. This is in spite of an intensely active MRI market in Germany where there are already many conventional lie-down MRIs installed.' Our German customer's comments on the benefits of the FONAR UPRIGHT® MRI technology are consistent with the success of our FONAR UPRIGHT® MRI scanners in the American MRI marketplace," said Dr. Damadian. "The treating physician in Germany quickly experiences the same result the treating physician in America experiences: A "BETTER PATIENT OUTCOME" for his patient."
The more accurate diagnosis available from the fully weight-loaded Multi-Position™ MRI provided by the FONAR UPRIGHT® as compared to the conventional weightless recumbent-only MRI examination enables a more complete and accurate diagnosis of the spine, which constitutes up to 60% of all MRI examinations, thereby optimizing the specific surgical or medical treatment selected for the patient. Since the PATIENT OUTCOME is the doctor's number one PRIORITY for his patient," said Dr. Damadian, "he quickly learns from firsthand experience that the FONAR UPRIGHT® MRI and its power to "SEE IT ALL" becomes indispensable towards his ultimate objective of optimizing the TREATMENT OUTCOMES OF HIS PATIENTS."
Dr. Damadian concluded: "During this quarter our MRI scanner product revenues increased and recently we reported sales to the UAE, Alaska, and Germany. Accordingly, I am optimistic about future sales of our UPRIGHT® Multi-Position™ MRI scanner."
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
I will be back later today with any changes and a comparison. This will be a different ball game from now on.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
Prior to Q1 2015 FONR's revenue was flat and EPS had a downward trend. This trend is history. Revenue and EPS are back on track. The last 5 quarters FONR's revenue and EPS have been: Q1 2014: $16.8M - $0.37 Q2 2014: $17.6M - $0.33 Q3 2014: $17.0M - $0.26 Q4 2014: $17.0M - $0.19 (add tax reversal of $0.43 and you get EPS of $0.62) Q1 2015: $18.0M - $0.38
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
finally a dip maybe I can pick up some more this week, here is a good reason,
How many Nasdaq stocks trading in the $11's just posted quarterly earnings of .38/share? Not to mention a solid balance sheet with nearly $2/share in cash. If anyone knows of other cheap stocks like FONR that are putting up big earnings that have yet to be appreciated by the market...please post them!
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
More profit rolls in for FONR. I was hoping for $17 million in revenue and $2 million in net income. FONR just posted $18 million in revenue and $2.4 million in net income. This company is growing and doing it profitably AND improving margins. Balance sheet is looking better and EPS is very strong. I think we will see over $15 per share
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
fonar is getting close to my buying number I hope it hits 10 soon I will add at that range. I will not be chasing it by the end of the year.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
I will start adding at ten almost there now. I have my first buy order in and waiting.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
Looks like another opportunity is heading our way time , to pick up a few shares in single digits.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
Bingo I just bought more fonar at under 10 not much mind you, Fonar 2 days later is now trading just over 11. I know that there will be news pretty soon, But don't believe me do your own DD.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
we will see in a couple of weeks how fonar is doing.
my guess is , $18 million in revenue and $2.8 million in net income for FONR for Q2 quarter.
If this is true or close to being true. it will be fonar's best quarter ever,
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
Revenues increased 2% to $35.1 million for the six month period ended December 31, 2014, from $34.4 million for the corresponding six month period one year earlier. Revenues for the second fiscal 2015 quarter ended December 31, 2014 were $17.1 million versus $17.6 million for the corresponding quarter one year earlier.
Net Income was $6.7 million for the six month period ended December 31, 2014 and the corresponding six month period one year earlier.
Net Income increased 13% to $3.5 million for the second fiscal 2015 quarter ended December 31, 2014 versus $3.0 million for the corresponding quarter one year earlier.
Income from Operations was $7.0 million for the six month period ended December 31, 2014, versus $7.3 million for the corresponding six month period one year earlier.
Income from Operations for the second fiscal 2015 quarter ended December 31, 2014 increased 9% to $3.6 million, from $3.3 million for the corresponding quarter one year earlier.
Diluted net income per common share available to common shareholders for the six month period ended December 31, 2014 was $0.79 versus $0.70 for the corresponding six month period one year earlier, an increase of 13%.
Diluted net income per common share available to common shareholders for the second fiscal 2015 quarter ended December 31, 2014 was $0.40 versus $0.33 for the corresponding quarter one year earlier, an increase of 21%.
Total assets at December 31, 2014 were $79.0 million, as compared to $76.8 million at June 30, 2014. Total current assets at December 31, 2014 were $46.8 million, as compared to $42.8 million at June 30, 2014.
Total liabilities at December 31, 2014 were $28.8 million, as compared to $30.9 million at June 30, 2014. Total current liabilities at December 31, 2014 were $20.9 million, as compared to $21.2 million at June 30, 2014.
Stockholder's equity at December 31, 2014 was $50.2 million, as compared to $45.9 million at June 30, 2014.
Cash and cash equivalents increased 17% to $11.7 million at December 31, 2014, from $10.0 million at June 30, 2014.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
January 18 2015 I posted: "I expect Q2 revenue of $18,6 - $18.9 million and net income of $3.2 - $3.4 million. Basic net income per common share available to common stockholders of 40 cents." Fonar just reported: Revenue of $17.1 million, net income of $3.5 million and Basic net income per common share available to common stockholders of 41 cents. The Q2 revenue was lower than I expected. In my forecast I expected at least 1 of 3 orders from October 2014 would be shipped before December 31. The net income is much better than my expectation if you consider the lower revenue. Gross profit from total revenue in Q2 2015 of 47.1% is significantly up from 44.5% in Q1 2015 and 45.1% in fiscal 2014. Another improvement in Q2 is Provisions for bad debts of only $273,000 compared to $506,000 in Q1 2015. Total Fonar Corporation Stockholder Equity of $30.6 million or book value of $5.0 per diluted share. Fonar's current assets reduced by total liabilities is $18.8 million or up by $3.0 million compared to Q1 2015 and up $5.9 million compared to June 2014. Fonar's cash and cash equivalents is now 40% of the company's total liabilities. Within 2 years Fonar's cash and cash equivalents surpasses its total liabilities.
At an average Basic net income per share of 40 cents per quarter Fonar's book value is going to reach $10 in 3 years. Cash and cash equivalents of $30 millions or half the book value of $10.
If Fonar in Q3 is able to ship 2 of the 3 MRI scanners in backlog ($1.5 million per MRI scanner) the basic net income is going to increase to 45 cents even if gross profit on the 2 MRI scanners is as low as 9%. Less
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
